# Severe Trauma Provokes Pathologic Continuum of Plasmin Activation

> **NIH NIH R01** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2020 · $357,000

## Abstract

1 Project Summary: Severe trauma is a significant cause of death and disability. Early in convalescence, it causes
 2 bleeding, thrombosis and multi-organ dysfunction syndrome; later in convalescence, it instigates pathologic
 3 tissue repair and homeostasis, which prevents return to activities of daily living. Severe trauma related death
 4 and disability is directly correlated with the degree of activation of pathologic activation of coagulation (trauma-
 5 induce coagulopathy (TIC)) and inflammation (systemic inflammatory response syndrome (SIRS)) suggesting
 6 that mitigating TIC and/or SIRS would reduce complications caused by severe trauma. There is a key knowledge
 7 gap regarding the molecular instigators of TIC and SIRS following severe trauma. Our preliminary data support
 8 a transformative hypothesis that implicates inappropriate early activation of plasmin, the principle protease of
 9 the fibrinolytic system essential for tissue repair and homeostasis, as a key event that initiates TIC and SIRS,
10 that also results in a prolonged loss of plasmin activity that disrupts tissue repair and homeostasis. Premise:
11 Following an isolated trauma, plasminogen activation is tightly regulated and restricted to the wound site.
12 However, following a severe trauma, plasmin is systemically activated (hyperfibrinolysis) followed by a prolonged
13 deficit of plasmin activity (hypofibrinolysis), both of which are associated with poor outcomes. Our central
14 hypothesis is that (i) early hyperfibrinolysis following severe trauma is a primary accelerant of TIC and SIRS,
15 (ii) early hyperfibrinolysis causes hypofibrinolysis by exhausting plasminogen, and that (iii) the acquired
16 plasminogen deficiency is a driver of pathologic tissue homeostasis and repair. Methods & Approach:
17 Employing a murine burn injury as a representative model of severe trauma, we will determine in Aim 1 whether
18 early hyperfibrinolysis accelerates TIC and SIRS and in Aim 2 whether early hyperfibrinolysis causes late
19 sustained hypofibrinolysis. Plasmin activity will be pharmacologically inhibited/enhanced and measured using
20 novel molecular tools. TIC and SIRS will be assessed with serial analysis of established biomarkers, platelet
21 function, and organ specific NF-κB quantification as a surrogate measure of multiorgan dysfunction syndrome.
22 The fibrinolytic system will be assessed by quantifying its individual elements, protease-inhibitor complexes,
23 fibrin degradation products, and activity assays. Next, in Aim 3 we will combine the murine burn model with a
24 femur fracture and skeletal muscle injury model to assess whether late hypofibrinolysis causes bone-related
25 pathologies; specifically impaired fracture healing, heterotopic ossification in muscle, and trauma-induced
26 osteoporosis. At the molecular level, we will determine if restoring plasmin activity prevents these bone
27 complications and to what extent of the bone pathologic processes are d...

## Key facts

- **NIH application ID:** 9904730
- **Project number:** 5R01GM126062-02
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Jonathan Schoenecker
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $357,000
- **Award type:** 5
- **Project period:** 2019-04-01 → 2023-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9904730

## Citation

> US National Institutes of Health, RePORTER application 9904730, Severe Trauma Provokes Pathologic Continuum of Plasmin Activation (5R01GM126062-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9904730. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
